Home/Filings/4/0001104659-21-047069
4//SEC Filing

Duncan Gregory Scott 4

Accession 0001104659-21-047069

CIK 0001818844other

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 3:38 PM ET

Size

4.7 KB

Accession

0001104659-21-047069

Insider Transaction Report

Form 4
Period: 2021-04-05
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Purchase

    Common Stock

    2021-04-05$6.17/sh+15,675$96,75719,579 total
Footnotes (1)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021.

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1
  • filerCIK 0001831127

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 3:38 PM ET
Size
4.7 KB